BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Zhang H, Hasim A, Tuerhong A, Hou Z, Abdurahmam A, Sheyhidin I. Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells. Med Sci Monit 2017;23:2382-90. [PMID: 28526815 DOI: 10.12659/msm.903380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Fu H, Wang Q, Li H, Gao J, Liu L, Tang B, Wei D, Xu B, Tong X, Li J, Luo Y. Partition defective 3 promotes TAZ nuclear localization and promotes Amphiregulin transcription to promote liver hepatocellular carcinoma cell invasion, migration and epithelial mesenchymal.. [DOI: 10.21203/rs.3.rs-1953346/v1] [Reference Citation Analysis]
2 Lv T, Xu J, Yuan H, Wang J, Jiang X. Dual Function of Par3 in Tumorigenesis. Front Oncol 2022;12:915957. [DOI: 10.3389/fonc.2022.915957] [Reference Citation Analysis]
3 Li X, Wu Q, Zhang X, Li C, Zhang D, Li G, Zhang Y, Zhao Y, Shi Z, Wang W, Li F. Whole-Genome Resequencing to Study Brucellosis Susceptibility in Sheep. Front Genet 2021;12:653927. [PMID: 34306007 DOI: 10.3389/fgene.2021.653927] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Atashrazm F, Ellis S. The polarity protein PARD3 and cancer. Oncogene 2021;40:4245-62. [PMID: 34099863 DOI: 10.1038/s41388-021-01813-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
5 Shen Z, Chai T, Luo F, Liu Z, Xu H, Zhang P, Kang M, Chen S. Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:4679-90. [PMID: 32547097 DOI: 10.2147/OTT.S243215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
6 Li J, Xu H, Wang Q, Fu P, Huang T, Anas O, Zhao H, Xiong N. Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling. Cancer Med 2019;8:2288-302. [PMID: 30848088 DOI: 10.1002/cam4.2063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]